loading
전일 마감가:
$12.78
열려 있는:
$12.61
하루 거래량:
91,189
Relative Volume:
0.08
시가총액:
$973.96M
수익:
$54.55M
순이익/손실:
$-193.57M
주가수익비율:
-4.4175
EPS:
-2.89
순현금흐름:
$-181.86M
1주 성능:
+15.16%
1개월 성능:
+38.21%
6개월 성능:
+10.76%
1년 성능:
-48.04%
1일 변동 폭
Value
$12.46
$12.79
1주일 범위
Value
$11.19
$13.23
52주 변동 폭
Value
$8.18
$29.56

누릭스 테라퓨틱스 Stock (NRIX) Company Profile

Name
명칭
Nurix Therapeutics Inc
Name
전화
(415) 660-5320
Name
주소
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Name
직원
286
Name
트위터
Name
다음 수익 날짜
2025-10-09
Name
최신 SEC 제출 서류
Name
NRIX's Discussions on Twitter

NRIX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
NRIX
Nurix Therapeutics Inc
12.74 1.30B 54.55M -193.57M -181.86M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.10 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
655.11 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
445.06 58.93B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
817.28 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
192.41 41.29B 398.11M -1.03B -868.57M -5.7032

누릭스 테라퓨틱스 Stock (NRIX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-10-21 개시 Mizuho Outperform
2025-03-17 개시 Leerink Partners Market Perform
2024-12-10 개시 BTIG Research Buy
2024-12-06 개시 BMO Capital Markets Outperform
2024-10-24 개시 UBS Buy
2024-10-11 개시 Jefferies Buy
2024-09-06 재개 Robert W. Baird Outperform
2024-07-31 개시 Truist Buy
2023-06-26 재개 Oppenheimer Outperform
2023-03-09 개시 Barclays Overweight
2023-02-28 개시 Oppenheimer Outperform
2022-10-11 개시 Morgan Stanley Equal-Weight
2022-05-31 업그레이드 Wells Fargo Equal Weight → Overweight
2022-02-10 개시 Wells Fargo Equal Weight
2021-12-29 개시 H.C. Wainwright Buy
2021-10-14 개시 SVB Leerink Outperform
2021-06-04 재개 Robert W. Baird Outperform
2021-04-30 재개 Piper Sandler Overweight
2021-04-30 개시 RBC Capital Mkts Outperform
2021-04-14 개시 Berenberg Buy
2020-11-19 개시 Robert W. Baird Outperform
2020-08-18 개시 JP Morgan Overweight
2020-08-18 개시 Needham Buy
2020-08-18 개시 Piper Sandler Overweight
2020-08-18 개시 Stifel Buy
모두보기

누릭스 테라퓨틱스 주식(NRIX)의 최신 뉴스

pulisher
05:20 AM

How institutional ownership impacts Nurix Therapeutics Inc. stock2025 Momentum Check & Safe Capital Preservation Plans - newser.com

05:20 AM
pulisher
04:45 AM

Full technical analysis of Nurix Therapeutics Inc. stockJuly 2025 Earnings & Long Hold Capital Preservation Tips - newser.com

04:45 AM
pulisher
04:18 AM

How moving averages guide Nurix Therapeutics Inc. tradingMarket Performance Report & Daily Risk Controlled Trade Plans - newser.com

04:18 AM
pulisher
01:49 AM

Will Nurix Therapeutics Inc. stock go up soonPortfolio Value Summary & Consistent Profit Trading Strategies - newser.com

01:49 AM
pulisher
01:47 AM

Nurix Therapeutics CFO van Houte sells $40k in shares By Investing.com - Investing.com UK

01:47 AM
pulisher
01:34 AM

Will Nurix Therapeutics Inc. stock deliver consistent dividendsQuarterly Trade Review & Risk Controlled Daily Plans - newser.com

01:34 AM
pulisher
01:05 AM

Can Nurix Therapeutics Inc. recover in the next quarter2025 Technical Overview & Weekly High Return Forecasts - newser.com

01:05 AM
pulisher
Oct 30, 2025

Nurix Therapeutics CLO ring sells shares for $46,631 By Investing.com - Investing.com Canada

Oct 30, 2025
pulisher
Oct 30, 2025

Nurix therapeutics CSO Hansen sells $52k in shares By Investing.com - Investing.com Philippines

Oct 30, 2025
pulisher
Oct 30, 2025

Nurix Therapeutics CFO van Houte sells $40k in shares - Investing.com

Oct 30, 2025
pulisher
Oct 30, 2025

Nurix therapeutics CSO Hansen sells $52k in shares - Investing.com

Oct 30, 2025
pulisher
Oct 30, 2025

Nurix Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Nurix Therapeutics (Nasdaq: NRIX) to join Stifel Nov 13 and Jefferies Nov 19 webcasts - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

Is Nurix Therapeutics Inc. building a consolidation baseInflation Watch & High Return Trade Guides - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

HC Wainwright Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $28.00 - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Visual trend scoring systems applied to Nurix Therapeutics Inc.July 2025 Retail & Technical Confirmation Trade Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

AlphaQuest LLC Boosts Holdings in Nurix Therapeutics, Inc. $NRIX - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Nurix Therapeutics Inc. stock daily chart insightsJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

What technical charts say about Nurix Therapeutics Inc. stockTrade Risk Report & Low Risk High Reward Ideas - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Nurix Therapeutics (NASDAQ:NRIX) Trading 7.7% HigherHere's Why - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

HC Wainwright & Co. Maintains Nurix Therapeutics (NRIX) Buy Recommendation - Nasdaq

Oct 28, 2025
pulisher
Oct 28, 2025

Nurix stock price target lowered to $28 at H.C. Wainwright on trial updates - Investing.com UK

Oct 28, 2025
pulisher
Oct 28, 2025

Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) 34% Price Boost Is Out Of Tune With Revenues - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

Will Nurix Therapeutics Inc. bounce back from current supportWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Applying chart zones and confluence areas to Nurix Therapeutics Inc.Weekly Trade Report & Long-Term Growth Stock Strategies - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics closes $250 million stock offering By Investing.com - Investing.com Philippines

Oct 27, 2025
pulisher
Oct 27, 2025

Why Nurix Therapeutics Inc. stock is seen as undervaluedQuarterly Trade Review & Safe Swing Trade Setup Alerts - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics’ NX-1607 Study: A Potential Game-Changer in Cancer Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics Advances NX-5948 Study in B-cell Malignancies - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics’ NX-2127 Study: A Potential Game-Changer in B-cell Malignancy Treatment - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics’ NX-5948 Study: A Potential Game-Changer in Drug Delivery - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Fenwick Represents Nurix Therapeutics in its $250M Registered Common Stock Offering - fenwick.com

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics closes $250 million stock offering - Investing.com

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock - Investing News Network

Oct 27, 2025
pulisher
Oct 27, 2025

Nurix (NASDAQ: NRIX) closes 24.5M-share offering at $10.21 for CLL, autoimmune - Stock Titan

Oct 27, 2025
pulisher
Oct 27, 2025

Leerink Partnrs Has Bullish Outlook for NRIX FY2025 Earnings - MarketBeat

Oct 27, 2025
pulisher
Oct 27, 2025

Can Nurix Therapeutics Inc. stock hit record highs againJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com

Oct 27, 2025

누릭스 테라퓨틱스 (NRIX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

누릭스 테라퓨틱스 주식 (NRIX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
van Houte Hans
Chief Financial Officer
Oct 30 '25
Sale
12.80
3,130
40,054
43,876
Ring Christine
Chief Legal Officer
Oct 30 '25
Option Exercise
0.00
10,532
0
54,541
Ring Christine
Chief Legal Officer
Oct 30 '25
Sale
12.80
3,644
46,631
50,897
Hansen Gwenn
Chief Scientific Officer
Oct 30 '25
Option Exercise
0.00
11,815
0
80,838
Hansen Gwenn
Chief Scientific Officer
Oct 30 '25
Sale
12.80
4,087
52,300
76,751
GREGORY JULIA P
Director
Sep 17 '25
Option Exercise
1.86
10,750
19,995
10,750
van Houte Hans
Chief Financial Officer
Aug 01 '25
Sale
11.03
5,402
59,598
35,512
$37.16
price up icon 0.51%
$28.58
price down icon 0.52%
$94.30
price up icon 1.81%
$104.33
price down icon 0.32%
biotechnology ONC
$309.46
price up icon 0.38%
$192.08
price down icon 1.15%
자본화:     |  볼륨(24시간):